Evidence map›Paper›PMID 37336886›Full record

ArticleOncogenesis2023

WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines.

Leigh A Bumpous, Kylie C Moe, Jing Wang, Logan A Carver, Alexandria G Williams, Alexander S Romer, Jesse D Scobee, Jack N Maxwell, Cheyenne A Jones, Dai H Chung and 3 more

Open access · goldAbstract read
In one paragraph

Article in Oncogenesis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Molecular regulation and therapeutic targeting ofFrontiers in cell and developmental biology · 2025
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Leigh A Bumpous *Department of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA.
Kylie C Moe *Department of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA.ORCID http://orcid.org/0000-0002-4697-974X
Jing WangCenter for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, 37240, USA.
Logan A CarverDepartment of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA.
Alexandria G WilliamsDepartment of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA.
Alexander S RomerDepartment of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA.
Jesse D ScobeeDepartment of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA.
Jack N MaxwellDepartment of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA.ORCID http://orcid.org/0009-0008-9362-3982
Cheyenne A JonesDepartment of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA.ORCID http://orcid.org/0000-0002-4806-8130
Dai H ChungDepartment of Pediatric Surgery, University of Texas Southwestern Medical Center and Children's Health, Dallas, TX, 75234, USA.
William P TanseyDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, 37240, USA.ORCID http://orcid.org/0000-0002-3900-0978
Qi LiuCenter for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, 37240, USA.
April M WeissmillerDepartment of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA. april.weissmiller@mtsu.edu.ORCID http://orcid.org/0000-0003-4505-0530
Middle Tennessee State University · USVanderbilt University Medical Center · USThe University of Texas Southwestern Medical Center · USVanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2019 to 2026
$19.6M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced GenomicsG20RR030956 · NCRR · VANDERBILT UNIVERSITY · PI PIETENPOL, JENNIFER A · 2010 to 2010
$8.7M
Facilitated recruitment of MYC to chromatin by interaction with WDR5R01CA200709 · NCI · VANDERBILT UNIVERSITY · PI TANSEY, WILLIAM PATRICK · 2016 to 2025
$3.9M
Determining the significance of the N-MYC-WDR5 interaction in neuroblastoma.R15CA263868 · NCI · MIDDLE TENNESSEE STATE UNIVERSITY · PI WEISSMILLER, APRIL M. · 2021 to 2021
$380k
NCI NIH HHS P30 CA068485NCI NIH HHS P50 CA236733NCI NIH HHS R01 CA200709NCI NIH HHS R15 CA263868NCRR NIH HHS G20 RR030956NCRR NIH HHS UL1 RR024975NEI NIH HHS P30 EY008126
6 · The paper itself

Abstract

Collectively, the MYC family of oncoprotein transcription factors is overexpressed in more than half of all malignancies. The ability of MYC proteins to access chromatin is fundamental to their role in promoting oncogenic gene expression programs in cancer and this function depends on MYC-cofactor interactions. One such cofactor is the chromatin regulator WDR5, which in models of Burkitt lymphoma facilitates recruitment of the c-MYC protein to chromatin at genes associated with protein synthesis, allowing for tumor progression and maintenance. However, beyond Burkitt lymphoma, it is unknown whether these observations extend to other cancers or MYC family members, and whether WDR5 can be deemed as a "universal" MYC recruiter. Here, we focus on N-MYC amplified neuroblastoma to determine the extent of colocalization between N-MYC and WDR5 on chromatin while also demonstrating that like c-MYC, WDR5 can facilitate the recruitment of N-MYC to conserved WDR5-bound genes. We conclude based on this analysis that N-MYC and WDR5 colocalize invariantly across cell lines at predicted sites of facilitated recruitment associated with protein synthesis genes. Surprisingly, we also identify N-MYC-WDR5 cobound genes that are associated with DNA repair and cell cycle processes. Dissection of chromatin binding characteristics for N-MYC and WDR5 at all cobound genes reveals that sites of facilitated recruitment are inherently different than most N-MYC-WDR5 cobound sites. Our data reveals that WDR5 acts as a universal MYC recruiter at a small cohort of previously identified genes and highlights novel biological functions that may be coregulated by N-MYC and WDR5 to sustain the neuroblastoma state.

Identifiers

PMID37336886
PMCPMC10279693
OpenAlexW4381190181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.